您当前的位置：
首页 >
文章列表页 >
扶正化瘀片成功完成美国食品药品管理局（FDA）Ⅱ期临床试验
更新时间：2021-11-17

    • 扶正化瘀片成功完成美国食品药品管理局（FDA）Ⅱ期临床试验

    • Journal of Traditional Chinese Medicine   Vol. 54, Issue 23, Pages: 1995(2013)

    • DOI：10.13288/j.11-2166/r.2013.23.001    

      CLC： R-5

    • Published：2013

    移动端阅览

  • 扶正化瘀片成功完成美国食品药品管理局（FDA）Ⅱ期临床试验[J]. Journal of Traditional Chinese Medicine2013, 54(23): 1995. DOI： 10.13288/j.11-2166/r.2013.23.001.

  •  
  •  
icon
试读结束，您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束，您可以通过登录账户，到个人中心，购买VIP会员阅读全文。
已是VIP会员？
去登录 >
查看原文

0

Views

84

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Construction and Application of a Real-World Cohort of Community-Acquired Pneumonia Based on a Multimodal Large-Scale Traditional Chinese Medicine Big Data Platform
Similarities and Differences between Myofascial Trigger Points and Sinew Knot：from the Perspective of the Channel Sinew Theory
WANG Qingguo's Experience in Treatment of Headache Based on the Concept of "Achieving Harmony by Unblocking and Balancing"
Effect of Xiaoqinglong Decoction （小青龙汤） on Th2 Immune Responses and Nasal Mucosal TSLP/OX40L Pathway in Allergic Rhinitis Model Rats
Efficacy and Economic Evaluation of Weishi Qingjin Formula （苇石清金方）in the Treatment of Adult Community-Acquired Pneumonia with Phlegm-Heat Obstructing the Lung Syndrome：A Multicenter Retrospective Real-World Cohort Study

Related Author

No data

Related Institution

No data
0